BRPI0507107A - compostos que se ligam a fator de crescimento e métodos de uso - Google Patents

compostos que se ligam a fator de crescimento e métodos de uso

Info

Publication number
BRPI0507107A
BRPI0507107A BRPI0507107-0A BRPI0507107A BRPI0507107A BR PI0507107 A BRPI0507107 A BR PI0507107A BR PI0507107 A BRPI0507107 A BR PI0507107A BR PI0507107 A BRPI0507107 A BR PI0507107A
Authority
BR
Brazil
Prior art keywords
growth factor
factor binding
binding compounds
methods
compounds
Prior art date
Application number
BRPI0507107-0A
Other languages
English (en)
Inventor
Said M Sebti
Andrew D Hamilton
Rishi Jain
Original Assignee
Univ South Florida
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida, Univ Yale filed Critical Univ South Florida
Publication of BRPI0507107A publication Critical patent/BRPI0507107A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSTOS QUE SE LIGAM A FATOR DE CRESCIMENTO E MéTODOS DE USO. A presente invenção refere-se a compostos que se ligam a fator de crescimento tendo uma pluralidade de grupos de ácido isoftálico acíclico ligados a uma plataforma orgânica de não peptídeo e composições farmacêuticas dos mesmos. Métodos de administração e de uso dos compostos que se ligam a fator de crescimento ou as composições que se ligam a fator de crescimento são também ensinadas. Esses novos compostos que se ligam a fator de crescimento são úteis para tratamento de angiogênese, proliferação celular excessiva, crescimento de tumor e uma combinação dos mesmos, assim como para inibição de fator de crescimento a células e de fosforilação.
BRPI0507107-0A 2004-01-27 2005-01-27 compostos que se ligam a fator de crescimento e métodos de uso BRPI0507107A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53961304P 2004-01-27 2004-01-27
PCT/US2005/003108 WO2005072779A2 (en) 2004-01-27 2005-01-27 Growth factor-binding compounds attached to a calixarene

Publications (1)

Publication Number Publication Date
BRPI0507107A true BRPI0507107A (pt) 2007-06-19

Family

ID=34826102

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507107-0A BRPI0507107A (pt) 2004-01-27 2005-01-27 compostos que se ligam a fator de crescimento e métodos de uso

Country Status (15)

Country Link
US (2) US7482483B2 (pt)
EP (1) EP1713510B1 (pt)
JP (1) JP4758359B2 (pt)
KR (1) KR20070008573A (pt)
CN (1) CN1921891B (pt)
AT (1) ATE460182T1 (pt)
AU (1) AU2005209305A1 (pt)
BR (1) BRPI0507107A (pt)
CA (1) CA2553674A1 (pt)
DE (1) DE602005019854D1 (pt)
ES (1) ES2339951T3 (pt)
HK (1) HK1096877A1 (pt)
IL (1) IL176898A (pt)
MX (1) MXPA06008408A (pt)
WO (1) WO2005072779A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157419B2 (en) 2000-03-21 2007-01-02 University Of South Florida Growth factor binding molecules
MXPA06008408A (es) 2004-01-27 2007-01-30 Univ South Florida Compuestos para union al factor de crecimiento unidos a un calixareno.
EP2404895A1 (en) 2004-10-04 2012-01-11 Regents of the University of Minnesota Calixarene-based peptide conformation mimetics, methods of use, and methods of making
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT316950B (de) 1969-09-16 1974-08-12 Var Spe S A S Di Speggiorin G Hydraulischer Geschwindigkeitswandler mit Radialkolben
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
CA2145190A1 (en) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services Use of taxol for treating lymphomas and breast cancer
US6262278B1 (en) 1995-03-14 2001-07-17 President And Fellows Of Harvard College Stereoselective ring opening reactions
US5665890A (en) * 1995-03-14 1997-09-09 President And Fellows Of Harvard College Stereoselective ring opening reactions
JP2000511880A (ja) * 1996-04-05 2000-09-12 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム カリックスピロール、カリックスピリジノピロールおよびカリックスピリジン
US5770380A (en) * 1996-09-13 1998-06-23 University Of Pittsburgh Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
US6521561B1 (en) * 1998-05-01 2003-02-18 President And Fellows Of Harvard College Main-group metal based asymmetric catalysts and applications thereof
US7157419B2 (en) * 2000-03-21 2007-01-02 University Of South Florida Growth factor binding molecules
WO2001070930A2 (en) * 2000-03-21 2001-09-27 University Of South Florida Growth factor binding molecules
KR100469213B1 (ko) * 2002-01-15 2005-02-02 학교법인 포항공과대학교 신규 칼릭사렌-뉴클레오시드 및칼릭사렌-올리고뉴클레오티드 혼성체와 그의 제조방법
MXPA06008408A (es) 2004-01-27 2007-01-30 Univ South Florida Compuestos para union al factor de crecimiento unidos a un calixareno.

Also Published As

Publication number Publication date
US7718700B2 (en) 2010-05-18
JP2007519748A (ja) 2007-07-19
CN1921891A (zh) 2007-02-28
US20050197401A1 (en) 2005-09-08
IL176898A (en) 2011-04-28
ATE460182T1 (de) 2010-03-15
AU2005209305A1 (en) 2005-08-11
EP1713510A2 (en) 2006-10-25
EP1713510B1 (en) 2010-03-10
KR20070008573A (ko) 2007-01-17
IL176898A0 (en) 2006-12-10
WO2005072779A2 (en) 2005-08-11
CA2553674A1 (en) 2005-08-11
JP4758359B2 (ja) 2011-08-24
WO2005072779A3 (en) 2006-03-23
US20090131487A1 (en) 2009-05-21
HK1096877A1 (en) 2007-06-15
MXPA06008408A (es) 2007-01-30
ES2339951T3 (es) 2010-05-27
US7482483B2 (en) 2009-01-27
CN1921891B (zh) 2010-11-10
DE602005019854D1 (de) 2010-04-22

Similar Documents

Publication Publication Date Title
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
BRPI0605921B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
ATE479687T1 (de) Kinaseinhibitoren
ATE523487T1 (de) 2-methylen-1-alpha-dihydroxy-19,21-dinor-vitami - d3-analoga und ihre anwendung
SV2010003463A (es) Compuestos organicos
DOP2011000171A (es) Compuestos organico
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
CO6321254A2 (es) Pirimidin -5-carboxamidas sustituidas 281
CU20070160A7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
EA200701707A1 (ru) Пиразолопиримидины
UY28734A1 (es) Compuestos de quinolina sustituidos
ATE471324T1 (de) Triazolophthalazine
BR112013001632A2 (pt) composto, composição farmacêutica, método de inibir uma atividade uma jak quinase in vitro, uso de um composto, ou da composição farmacêutica, e, método de fabricar um composto
UY30127A1 (es) Derivados de acidos antranilicos fenoxi y feniltio, composiciones farmaceuticas que los contienen y su uso.
BRPI0519292A2 (pt) compostos orgÂnicos
BRPI0508102A (pt) inibidores de caspase e usos dos mesmos
UY27851A1 (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
DK1848442T3 (da) 2-methylene-19-nor-(20s-24epi)-1alfa,25-dihydroxyvitamine-d2
BRPI0507107A (pt) compostos que se ligam a fator de crescimento e métodos de uso
BR0016638B1 (pt) compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
CO5540291A2 (es) Benzamidoacetonitrilos y su uso como antiparasitarios
ATE499942T1 (de) 2-methylen-19,21-dinor-1alpha-hydroxy- bishomopregnacalciferol
BRPI0507283A (pt) compostos orgánicos
GT200700006A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A, 10A E 11A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: B82Y 5/00 (2011.01), A61K 47/54 (2017.01), A61K 47